Financials
Financial year 2024
NMC MED from Nandrin, company number BE0727589278, closed financial year 2024 with a result of € 61,571 after tax. For that financial year NMC MED recorded a gross margin of € 113,156 and equity of € 120,661. Compared with financial year 2023, the result moved from € 94,883 to € 61,571. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2025.
€ 120,661
▲ 104% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 61,571
▼ 35% vs 2023
Profit after tax over the fiscal year.
€ 69,434
▲ 60% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 118,161.
People and assets in 2024
€ 7,136
Of which on lease € 5,356.
Debts at end 2024
€ 88,907
▼ 22% vs 2023
€ 25,111 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 1,871
▼ 39% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 31,022
▼ 52% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 80,279 | € 142,817 | € 152,495 | € 113,156 | ▼ 26% |
| Profit after taxes | € 43,533 | € 88,829 | € 94,883 | € 61,571 | ▼ 35% |
| Equity | € 55,377 | € 144,206 | € 59,089 | € 120,661 | ▲ 104% |
| Total debts | € 186,626 | € 153,162 | € 213,830 | € 141,367 | ▼ 34% |
| Cash | € 20,877 | € 15,055 | € 43,320 | € 69,434 | ▲ 60% |
| Land & buildings | - | - | - | € 5,026 | |
| Retained profit | € 52,877 | € 141,706 | € 56,589 | € 118,161 | ▲ 109% |
| Dividend | € 20,000 | € 0 | € 180,000 | € 0 | ▼ 100% |
| Bank debt | € 162,871 | € 138,441 | € 113,786 | € 88,907 | ▼ 22% |
| Balance sheet total | € 242,004 | € 297,368 | € 272,919 | € 262,027 | ▼ 4% |
Key figures of NMC MED, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to NMC MED?
What happened at NMC MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 61,571 (▼ 35% vs 2023). filed late Source: NBB ↗
- New establishment in Charleroi. KBO
- New establishment in Huy. KBO
- Start of the company according to the CBE. KBO
In short
From € 43,533 profit in 2021 to € 61,571 profit in 2024.
Paid € 85,695 in corporate taxes since 2021.
Best year ever: 2023, with € 94,883 profit.
Paid out € 200,000 in dividends to the owners in total.
Management
Behind NMC MED are Nicolas Marchant and Caroline Ramquet.
Directors
According to the 2024 annual accounts
Nicolas Marchant
Director
Caroline Ramquet
Director
Establishments
Establishment units
Physical locations of this company
Rue de la Croix André 12
4550 Nandrin
Grand'rue 3
6000 Charleroi
Active since 1 October 2021
Rue des Trois-Ponts 2
4500 Huy
Active since 28 May 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0727.589.278
- VAT number
- BE 0727.589.278
- Registered office
- Rue de la Croix André 12, 4550 Nandrin
- Names & denominations
- NMC MED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 May 2019
- Peppol
- Active · Active since 29 Sept 2026
- Activities · NACE
Activiteiten van medisch specialisten